Bristol Myers Squibb

@bmsnews

We work every day to transform patients’ lives through science. See our community guidelines: one.bms.com/3WHdbIG

New York, New York

Bristol Myers Squibb
@bmsnews
Oct 1
Healthcare professionals make an extraordinary difference every day. #ChampionsInCare is back, introducing a new $1 million community grant program for medically underserved communities. Together, we're building a world of gratitude. bit.ly/4rGexSV
00:00
Bristol Myers Squibb
@bmsnews
Sep 30
#MEDIA: The U.S. FDA approved an expanded indication for our first-in-class treatment for adults and certain pediatric patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). bit.ly/4e53nkY
00:00
Bristol Myers Squibb
@bmsnews
Sep 25
#MEDIA: Announcing first disclosure of results from a Phase 3 trial evaluating our treatment for certain adult patients with #MultipleMyeloma at #IMS26. bit.ly/4rPS1ax
00:00
2
Bristol Myers Squibb
@bmsnews
Sep 17
#MEDIA: Today at #CCRWest2026, we announced two-year results from the Phase 3 study evaluating an approved medicine for adults with active #PsoriaticArthritis (PsA). Read more: bit.ly/4AnsaKQ
1
Bristol Myers Squibb
@bmsnews
Sep 8
#MEDIA: Announcing positive topline results from a Phase 2 trial of an investigational #CARTCellTherapy for certain patients with relapsed or refractory multiple myeloma. bit.ly/4gJ1FYA
2